Trellist Marketing and Technology is pleased to announce that it has partnered with a leading pharmaceutical company for a new social media marketing engagement. As part of this contract, Trellist will develop a social media strategy and provide creative execution to promote the company's novel dermatological therapy.
Designed to help treat actinic keratosis of the face and scalp, the therapy is expected to provide a quicker and more comfortable way to treat the condition, with fewer side effects. The client will use social media to build awareness of this product and provide a place where patients and physicians can connect and share their experiences with it.
"Social media for pharma can be a challenge; content must comply with government and channel regulations and any comments from patients regarding side effects must be reported to the FDA," explains Melissa Stevens, Strategic Lead for Consulting and Account Services at Trellist. "However, our past experience in healthcare and social media, along with our highly skilled and efficient teams, gives us an advantage over other companies in this space."
"We're already working on a process and content strategy for this campaign, and once we have that settled, we can start managing an effective social presence for the brand," Stevens added. "This is an exciting opportunity to promote a new, high-value drug that has the potential to bring about a significantly improved patient experience."
To learn more about Trellist's capabilities for the pharmaceutical industry, visit https://www.trellist.com/industries/healthcare
We’d love to have a conversation with you about how Trellist can help you engage your customers and maximize growth. Start by providing us some details in the form below.
To see career opportunities, apply for a job, or submit your resume, visit our Careers section.
Required
